We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
LivaNova
LIVN
$4.3B
| $7.73M | 0.07% |
+143,180
| New | +$7.96M |
|
|
ATML
252
DELISTED
ATMEL CORP
ATML
| $7.68M | 0.07% |
946,010
+22,718
| +2% | +$183K |
|
253
MSC Industrial Direct
MSM
$7.02B
| $7.65M | 0.07% |
+100,255
| New | +$6.72M |
|
|
OPLN
254
Openlane
OPLN
$4.17B
| $7.61M | 0.07% |
527,441
-812,164
| -61% | -$10.8M |
|
|
KNL
255
DELISTED
Knoll, Inc.
KNL
| $7.58M | 0.07% |
350,261
+274,971
| +365% | +$5.16M |
|
256
United Therapeutics
UTHR
$26.3B
| $7.57M | 0.07% |
67,886
+65,899
| +3,317% | +$8.34M |
|
257
Crown Holdings
CCK
$12.8B
| $7.53M | 0.07% |
151,826
+110,416
| +267% | +$5.18M |
|
258
Baidu
BIDU
$35.8B
| $7.52M | 0.07% |
39,392
+28,101
| +249% | +$4.78M |
|
259
Newell Brands
NWL
$2.16B
| $7.39M | 0.07% |
166,881
-190,310
| -53% | -$7.46M |
|
260
NVIDIA
NVDA
$5.01T
| $7.33M | 0.07% |
8,229,920
-87,880
| -1% | -$67K |
|
|
JAH
261
DELISTED
JARDEN CORPORATION
JAH
| $7.3M | 0.07% |
123,927
+23,117
| +23% | +$1.24M |
|
262
NetApp
NTAP
$32.9B
| $7.27M | 0.07% |
266,533
-600,727
| -69% | -$14.6M |
|
|
ATVI
263
DELISTED
Activision Blizzard
ATVI
| $7.22M | 0.07% |
213,350
+23,361
| +12% | +$766K |
|
|
CTXS
264
DELISTED
Citrix Systems Inc
CTXS
| $7.16M | 0.07% |
114,393
-56,377
| -33% | -$3.19M |
|
265
Monolithic Power Systems
MPWR
$65.5B
| $7.16M | 0.07% |
+112,459
| New | +$6.7M |
|
266
Tower Semiconductor
TSEM
$26.4B
| $7.14M | 0.07% |
+589,128
| New | +$7.41M |
|
267
MBIA
MBI
$288M
| $7.13M | 0.07% |
805,442
+586,855
| +268% | +$4.27M |
|
268
Urban Outfitters
URBN
$5.99B
| $7.01M | 0.07% |
+211,928
| New | +$5.6M |
|
269
EPAM Systems
EPAM
$4.69B
| $6.97M | 0.07% |
+93,413
| New | +$6.45M |
|
|
ACHN
270
DELISTED
Achillion Pharmaceuticals
ACHN
| $6.96M | 0.07% |
902,202
-68,660
| -7% | -$503K |
|
271
Philip Morris
PM
$301B
| $6.96M | 0.07% |
+70,914
| New | +$6.5M |
|
|
DISH
272
DELISTED
DISH Network Corp.
DISH
| $6.95M | 0.07% |
150,310
+96,199
| +178% | +$4.64M |
|
273
IQVIA
IQV
$34.7B
| $6.95M | 0.07% |
106,675
-131,195
| -55% | -$8.3M |
|
274
Reliance Steel & Aluminium
RS
$20.8B
| $6.91M | 0.07% |
+99,831
| New | +$6.04M |
|
|
BERY
275
DELISTED
Berry Global Group, Inc.
BERY
| $6.9M | 0.07% |
207,946
-386,965
| -65% | -$11.3M |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.